PPARA and colorectal cancer: This could be due to the unique nature of CBG, which has been found to be an agonist of α2-adrenogeric receptors [42] and peroxisome proliferator-activated receptors (PPAR) α and γ [43,44,45,46], and the activation of these receptors has previously been reported to inhibit colorectal cancer cell growth.